(Q41534080)

2 October 2017

1 reference

title

A review of the use of augmentation therapy for the treatment of resistant depression: implications for the clinician (English)

1 reference

2 October 2017

I Schweitzer

1

1 reference

2 October 2017

V Tuckwell

series ordinal

2

1 reference

2 October 2017

G Johnson

series ordinal

3

1 reference

2 October 2017

publication date

1 June 1997

1 reference

Australian and New Zealand Journal of Psychiatry

2 October 2017

published in

1 reference

2 October 2017

volume

31

1 reference

2 October 2017

issue

3

1 reference

2 October 2017

page(s)

340-352

1 reference

Treatment resistant depression in an Australian context. I: The utility of the term and approaches to management.

2 October 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Treatment-resistant depression: a critique of current approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Outcome of depression in psychiatric settings

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

The effects of lithium carbonate in combination with tricyclic antidepressants in endogenous depression. A double-blind, multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Lithium Augmentation in Antidepressant-Resistant Patients a Quantitative Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Refractory depression: the addition of lithium to fluoxetine or desipramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Tolerability of combined treatment with lithium and paroxetine: 19 cases treated under open conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Lithium augmentation therapy in tricyclic-resistant depression. A controlled trial using lithium in low and normal doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Predictors of response to lithium and triiodothyronine augmentation of antidepressants in tricyclic non-responders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Lithium treatment and serotoninergic function. Neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Lithium in Tricyclic-Resistant Depression Correlation of Increased Brain 5-HT Function with Clinical Outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Initiation and adaptation: a paradigm for understanding psychotropic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

21 January 2018

The serotonin syndrome

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Serotonin syndrome produced by a combination of fluoxetine and lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Absence seizures induced by lithium: possible interaction with fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Thyroid hormones in the treatment of affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Failure of T3 to potentiate tricyclic antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

A hypothesis of thyroid-catecholamine-receptor interaction. Its relevance to affective illness

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Serious adverse effects of combining fluoxetine and tricyclic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Rapid down regulation of beta-adrenoceptors by co-administration of desipramine and fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Effectiveness of Pindolol With Selected Antidepressant Drugs in the Treatment of Major Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Carbamazepine addition in tricyclic antidepressant-resistant unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

A potential clinical use for methylphenidate with tricyclic antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Augmentation with buspirone: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Duration of antidepressant drug treatment. What is an adequate trial?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

Tricyclic Augmentation of Fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048679709073843

10.3109/00048679709073843

21 January 2018

Identifiers

DOI

1 reference

2 October 2017

1 reference